Skip To Content

News & Events: SPACS

Posts

  • August 09 2024

    Healthcare-Focused SPAC Voyager Nets $220M IPO

    Shares of healthcare-focused Voyager Acquisition Corp. began trading publicly on Friday after the company priced its $220 million initial public offering.  The special purpose acquisition company on Thursday announced plans to raise $220 million in its IPO by offering 22 million units for $10 apiece, according to a Thursday statement. The units began trading on the Nasdaq on Friday under ticker symbol VACHU.

    www.law360.com

  • August 01 2024

    Catalyst Partners files to launch Egypt’s 1st SPAC

    Catalyst Partners has submitted paperwork to establish Egypt’s first Special Purpose Acquisition Company (SPAC), the firm announced on Tuesday. The company, named Catalyst Partners Middle East, will operate as a venture capital firm focusing on acquiring businesses in the non-banking financial services and fintech sectors.

    www.dailynewsegypt.com

  • July 25 2024

    SPAC DT Cloud Star Acquisition prices $60 million IPO, led by CITIC Securities exec

    DT Cloud Star Acquisition, a blank check company led by an executive from CITIC Securities, raised $60 million by offering 6 million units at $10. Each unit consists of one share of common stock and one right to receive one-ninth of a share upon the completion of an initial business combination.

    www.renaissancecapital.com

  • July 24 2024

    Bitcoin Reward Firm Fold to Go Public Via Betsy Cohen SPAC

    Fold Inc., the Bitcoin reward firm, has agreed to go public via merging with a blank-check company started by SPAC veteran Betsy Cohen.  The deal with FTAC Emerald Acquisition Corp. gives Fold a pre-money equity valuation of $365 million, according to a Wednesday statement, confirming an earlier Bloomberg News report.

    www.bloomberg.com

  • July 23 2024

    Phytanix Bio to go public with Chain Bridge SPAC in $58 million deal

    It’s been a minute since the market has seen a medical cannabis company go public via a SPAC. Phytanix Bio, a pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules is going public through a Special Purpose Acquisition Corp. called Chain Bridge I (Nasdaq: CBRG).

    www.greenmarketreport.com

  • July 22 2024

    Auditor ‘Going Concern’ Warnings Tumble After SPAC-Driven Spike

    The number of auditors of public companies who had substantial doubts about the businesses staying afloat fell in 2023.  Auditors of 21.9% of public companies last year had doubts about their clients’ ability to continue as “going concerns,” down from 24.3% in 2022, according to a new Ideagen Audit Analytics report. The study analyzed annual reports for US companies and foreign groups that file with US regulators.

    www.news.bloombergtax.com

  • July 18 2024

    Veteran SPAC Sponsors Drive $1.7 Billion Surge in Just Six Weeks

    Michael Andretti, Howard Lutnick and James Graf are among the serial sponsors returning to a US blank-check market that’s been heating up over the past six weeks, with mostly seasoned backers attracting $1.7 billion between them.

    www.bloomberg.com

  • July 17 2024

    Nasdaq Seeks To Tighten Delisting Rules Governing SPACs

    Nasdaq is proposing to strengthen its rules governing delistings and trading suspensions of special-purpose acquisition companies that fail to complete mergers within 36-month deadlines or that violate other listing standards.

    www.law360.com

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”